Table 1 Treatment success by Treatment era.

From: Survival trend in metastatic prostate cancer two decades of real-world data on overall survival from Germany

Era

Years

n

Median OS (95% CI)

Comparison Test

p-value

Pre-Taxanes

1999-2003

6474

31.5 (30.8-32.2)

Reference

-

Taxanes

2004-2010

11,234

33.0 (32.5-33.5)

Log-rank vs.

Pre-Taxanes

0.018

ARPI

2011-2016

17,823

35.0 (34.4-35.6)

Log-rank vs. Taxanes

0.002

Contemporary

2017-2021

19,359

37.5 (36.8-38.2)

Log-rank vs

ARPI

<0.001

Back to article page